Search research articles
Contact Us
Filters
Showing results (1-10 of 74) with videos related to
Page
of 8
Sort By:
Therapeutic Advances in Medical Oncology
|
March 14, 2020
How and when to refer patients for oncogenetic counseling in the era of PARP inhibitors
Zoé Neviere, Thibault De La Motte Rouge, Anne Floquet, et al.
Journal of Genetic Counseling
|
January 25, 2013
Comparison of the screening practices of unaffected noncarriers under 40 and between 40 and 49 in BRCA1/2 families
Christelle Duprez, Véronique Christophe, Isabelle Milhabet, et al.
Breast Cancer Research and Treatment
|
September 18, 2010
Two novel variants in the 3'UTR of the BRCA1 gene in familial breast and/or ovarian cancer
Stéphanie Lheureux, Bernard Lambert, Sophie Krieger, et al.
Bulletin Du Cancer
|
October 9, 2014
[Gliomas and BRCA genes mutations: fortuitous association or imputability?]
Laura Girardstein-Boccara, Véronique Mari, Marie Met-Domestici, et al.
Journal of Medical Genetics
|
June 5, 2010
The BRCA1 c.5434C->G (p.Pro1812Ala) variant induces a deleterious exon 23 skipping by affecting exonic splicing regulatory elements
Pascaline Gaildrat, Sophie Krieger, Jean-Christophe Théry, et al.
European Journal of Human Genetics : EJHG
|
January 21, 2011
Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and Quebec
Michel Dorval, Catherine Noguès, Pascaline Berthet, et al.
European Journal of Human Genetics : EJHG
|
January 27, 2011
Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations
Claire Julian-Reynier, Julien Mancini, Emmanuelle Mouret-Fourme, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 30, 2004
Risk of second primary cancer following differentiated thyroid cancer
Emmanuelle Berthe, Michel Henry-Amar, Jean-Jacques Michels, et al.
Psychology, Health & Medicine
|
September 12, 2019
Parental disclosure of positive <i>BRCA1/2</i> mutation status to children 10 years after genetic testing
Jaïs Troïan, Thémis Apostolidis, Rajae Touzani, et al.
World Journal of Gastroenterology
|
January 14, 2014
Evaluation of the colorectal cancer risk conferred by rare UNC5C alleles
Sébastien Küry, Céline Garrec, Fabrice Airaud, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 74) with videos related to
Sort By:
Page
of 8
Therapeutic Advances in Medical Oncology
|
March 14, 2020
How and when to refer patients for oncogenetic counseling in the era of PARP inhibitors
Zoé Neviere, Thibault De La Motte Rouge, Anne Floquet, et al.
Journal of Genetic Counseling
|
January 25, 2013
Comparison of the screening practices of unaffected noncarriers under 40 and between 40 and 49 in BRCA1/2 families
Christelle Duprez, Véronique Christophe, Isabelle Milhabet, et al.
Breast Cancer Research and Treatment
|
September 18, 2010
Two novel variants in the 3'UTR of the BRCA1 gene in familial breast and/or ovarian cancer
Stéphanie Lheureux, Bernard Lambert, Sophie Krieger, et al.
Bulletin Du Cancer
|
October 9, 2014
[Gliomas and BRCA genes mutations: fortuitous association or imputability?]
Laura Girardstein-Boccara, Véronique Mari, Marie Met-Domestici, et al.
Journal of Medical Genetics
|
June 5, 2010
The BRCA1 c.5434C->G (p.Pro1812Ala) variant induces a deleterious exon 23 skipping by affecting exonic splicing regulatory elements
Pascaline Gaildrat, Sophie Krieger, Jean-Christophe Théry, et al.
European Journal of Human Genetics : EJHG
|
January 21, 2011
Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and Quebec
Michel Dorval, Catherine Noguès, Pascaline Berthet, et al.
European Journal of Human Genetics : EJHG
|
January 27, 2011
Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1/2 mutations
Claire Julian-Reynier, Julien Mancini, Emmanuelle Mouret-Fourme, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
January 30, 2004
Risk of second primary cancer following differentiated thyroid cancer
Emmanuelle Berthe, Michel Henry-Amar, Jean-Jacques Michels, et al.
Psychology, Health & Medicine
|
September 12, 2019
Parental disclosure of positive <i>BRCA1/2</i> mutation status to children 10 years after genetic testing
Jaïs Troïan, Thémis Apostolidis, Rajae Touzani, et al.
World Journal of Gastroenterology
|
January 14, 2014
Evaluation of the colorectal cancer risk conferred by rare UNC5C alleles
Sébastien Küry, Céline Garrec, Fabrice Airaud, et al.
Page
of 8